Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial

Journal of Clinical Oncology

Volumn 16, Issue 7, 1998, Pages 2445-2451

  Northfelt, Donald W ^a   Dezube, Bruce J ^a   Thommes, James A ^a   Miller, Becky J ^a   Fischl, Margaret A ^a   Friedman Kien, Alvin ^a   Kaplan, Lawrence D ^a   Du Mond, Charles ^a   Mamelok, Richard D ^a   Henry, David H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DOXORUBICIN; LIPOSOME; MACROGOL; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; KAPOSI SARCOMA; MALE; NEUROPATHY; PARESTHESIA; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; STOMATITIS; TREATMENT OUTCOME;

EID: 0031861021     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.7.2445     Document Type: Article

References (21)

1. Beral V, Peterman TA, Berkelman RL, et al: Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection. Lancet 1:123-128, 1990
2. Northfelt DW. AIDS-related Kaposi's sarcoma: Still a problem, still an opportunity. J Clin Oncol 12:1109-1110, 1994
3. Northfelt DW: Treatment of Kaposi's sarcoma: Current guidelines and future perspectives. Drugs 48:569-582, 1994
4. Gill PS, Wernz J, Scadden DT, et al: Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 14:2353-2364, 1996
5. Gabizon A: Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 52:891-896, 1992
6. Uziely B, Jeffers S, Isacson R, et al: Liposomal doxorubicin: Antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol 13:1777-1785, 1995
7. Gabizon A, Barenholz Y, Bialer M: Prolongation of circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: Pharmacokinetic studies in rodents and dogs. Pharmaceut Res 10:703-708, 1993
8. Huang SK, Mayhew E, Gilani S: Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res 52:6774-6781, 1992
9. Northfelt DW, Martin FJ, Working P, et al: Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 36:55-63, 1996
10. Northfelt DW, Dezube BJ, Thommes JA, et al: Efficacy of pegylated-liposomal doxorubicin in the treatment of AIDS-related Kaposi's sarcoma after failure of standard chemotherapy. J Clin Oncol 15:653-659, 1997
11. Stewart S, Jablonowski H, Goebel FD, et al: Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol 16:683-691, 1998
12. Krown SE, Metroka C, Wernz JC: Kaposi's sarcoma in the acquired immunodeficiency syndrome: A proposal for uniform evaluation, response, and staging criteria. J Clin Oncol 7:1201-1207, 1989
13. World Health Organization: Handbook for Reporting Results of Cancer Treatment. Offset publication no. 48. Geneva, Switzerland, World Health Organization, 1979
14. Amantea MA, Forest A, Northfelt DW, et al: Population pharmacokinetics and pharmacodynamics of pegylated-liposomal doxorubicin in patients with AIDS-related Kaposi's sarcoma. Clin Pharmacol Therapeut 61:301-311, 1997
15. Gill PS, Rarick M, McCutchan JA, et al: Systemic treatment of AIDS-related Kaposi's sarcoma: results of a randomized trial. Am J Med 90:427-433, 1991
16. Fischl MA, Krown SE, O'Boyle KP, et al: Weekly doxorubicin in the treatment of patients with AIDS-related Kaposi's sarcoma. J Acquir Immun Defic Synd 6:259-264, 1993
17. Remick SC, Reddy M, Herman D, et al: Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma. J Clin Oncol 12:1130-1136, 1994
18. Saville MW, Lietzman J, Pluda JM, et al: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26-28, 1995
19. Gill P, Rarick M, Bernstein-Singer M, et al: Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 13:315-319, 1990
20. Rarick MU, Gill PS, Montgomery T, et al: Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine. Ann Oncol 1:147-149, 1990
21. Laubenstein LJ, Krigel RL, Odajnyk CM, et al: Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine. J Clin Oncol 2:1115-1120, 1984